Report Detail

Other Global Active Transdermal Drug Delivery Device Market Research Report 2019

  • RnM2745100
  • |
  • 09 January, 2019
  • |
  • Global
  • |
  • 115 Pages
  • |
  • QYResearch
  • |
  • Other

This report studies the global Active Transdermal Drug Delivery Device market status and forecast, categorizes the global Active Transdermal Drug Delivery Device market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).

The major manufacturers covered in this report
Novartis AG
Noven Pharmaceuticals, Inc.
Transdermal Corp.
Johnson & Johnson (Janssen Pharmaceuticals Inc.)
Mylan N.V.
3M
Actavis, Inc.
Bayer AG
Boehringer Ingelheim GmbH
Corium International, Inc.
Echo Therapeutics, Inc.
GlaxoSmithKline plc

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Patches
Gels
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Clinic
Hospital
Home Use

The study objectives of this report are:
To analyze and study the global Active Transdermal Drug Delivery Device capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Active Transdermal Drug Delivery Device manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Active Transdermal Drug Delivery Device are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Active Transdermal Drug Delivery Device Manufacturers
Active Transdermal Drug Delivery Device Distributors/Traders/Wholesalers
Active Transdermal Drug Delivery Device Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Active Transdermal Drug Delivery Device market, by end-use.
Detailed analysis and profiles of additional market players.


Table of Contents

    Global Active Transdermal Drug Delivery Device Market Research Report 2018

      1 Active Transdermal Drug Delivery Device Market Overview

      • 1.1 Product Overview and Scope of Active Transdermal Drug Delivery Device
      • 1.2 Active Transdermal Drug Delivery Device Segment by Type (Product Category)
        • 1.2.1 Global Active Transdermal Drug Delivery Device Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
        • 1.2.2 Global Active Transdermal Drug Delivery Device Production Market Share by Type (Product Category) in 2017
        • 1.2.3 Patches
        • 1.2.3 Gels
      • 1.3 Global Active Transdermal Drug Delivery Device Segment by Application
        • 1.3.1 Active Transdermal Drug Delivery Device Consumption (Sales) Comparison by Application (2013-2025)
        • 1.3.2 Clinic
        • 1.3.3 Hospital
        • 1.3.4 Home Use
      • 1.4 Global Active Transdermal Drug Delivery Device Market by Region (2013-2025)
        • 1.4.1 Global Active Transdermal Drug Delivery Device Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
        • 1.4.2 North America Status and Prospect (2013-2025)
        • 1.4.3 Europe Status and Prospect (2013-2025)
        • 1.4.4 China Status and Prospect (2013-2025)
        • 1.4.5 Japan Status and Prospect (2013-2025)
        • 1.4.6 Southeast Asia Status and Prospect (2013-2025)
        • 1.4.7 India Status and Prospect (2013-2025)
      • 1.5 Global Market Size (Value) of Active Transdermal Drug Delivery Device (2013-2025)
        • 1.5.1 Global Active Transdermal Drug Delivery Device Revenue Status and Outlook (2013-2025)
        • 1.5.2 Global Active Transdermal Drug Delivery Device Capacity, Production Status and Outlook (2013-2025)

      2 Global Active Transdermal Drug Delivery Device Market Competition by Manufacturers

      • 2.1 Global Active Transdermal Drug Delivery Device Capacity, Production and Share by Manufacturers (2013-2018)
        • 2.1.1 Global Active Transdermal Drug Delivery Device Capacity and Share by Manufacturers (2013-2018)
        • 2.1.2 Global Active Transdermal Drug Delivery Device Production and Share by Manufacturers (2013-2018)
      • 2.2 Global Active Transdermal Drug Delivery Device Revenue and Share by Manufacturers (2013-2018)
      • 2.3 Global Active Transdermal Drug Delivery Device Average Price by Manufacturers (2013-2018)
      • 2.4 Manufacturers Active Transdermal Drug Delivery Device Manufacturing Base Distribution, Sales Area and Product Type
      • 2.5 Active Transdermal Drug Delivery Device Market Competitive Situation and Trends
        • 2.5.1 Active Transdermal Drug Delivery Device Market Concentration Rate
        • 2.5.2 Active Transdermal Drug Delivery Device Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Active Transdermal Drug Delivery Device Capacity, Production, Revenue (Value) by Region (2013-2018)

      • 3.1 Global Active Transdermal Drug Delivery Device Capacity and Market Share by Region (2013-2018)
      • 3.2 Global Active Transdermal Drug Delivery Device Production and Market Share by Region (2013-2018)
      • 3.3 Global Active Transdermal Drug Delivery Device Revenue (Value) and Market Share by Region (2013-2018)
      • 3.4 Global Active Transdermal Drug Delivery Device Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.5 North America Active Transdermal Drug Delivery Device Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.6 Europe Active Transdermal Drug Delivery Device Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.7 China Active Transdermal Drug Delivery Device Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.8 Japan Active Transdermal Drug Delivery Device Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.9 Southeast Asia Active Transdermal Drug Delivery Device Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.10 India Active Transdermal Drug Delivery Device Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

      4 Global Active Transdermal Drug Delivery Device Supply (Production), Consumption, Export, Import by Region (2013-2018)

      • 4.1 Global Active Transdermal Drug Delivery Device Consumption by Region (2013-2018)
      • 4.2 North America Active Transdermal Drug Delivery Device Production, Consumption, Export, Import (2013-2018)
      • 4.3 Europe Active Transdermal Drug Delivery Device Production, Consumption, Export, Import (2013-2018)
      • 4.4 China Active Transdermal Drug Delivery Device Production, Consumption, Export, Import (2013-2018)
      • 4.5 Japan Active Transdermal Drug Delivery Device Production, Consumption, Export, Import (2013-2018)
      • 4.6 Southeast Asia Active Transdermal Drug Delivery Device Production, Consumption, Export, Import (2013-2018)
      • 4.7 India Active Transdermal Drug Delivery Device Production, Consumption, Export, Import (2013-2018)

      5 Global Active Transdermal Drug Delivery Device Production, Revenue (Value), Price Trend by Type

      • 5.1 Global Active Transdermal Drug Delivery Device Production and Market Share by Type (2013-2018)
      • 5.2 Global Active Transdermal Drug Delivery Device Revenue and Market Share by Type (2013-2018)
      • 5.3 Global Active Transdermal Drug Delivery Device Price by Type (2013-2018)
      • 5.4 Global Active Transdermal Drug Delivery Device Production Growth by Type (2013-2018)

      6 Global Active Transdermal Drug Delivery Device Market Analysis by Application

      • 6.1 Global Active Transdermal Drug Delivery Device Consumption and Market Share by Application (2013-2018)
      • 6.2 Global Active Transdermal Drug Delivery Device Consumption Growth Rate by Application (2013-2018)
      • 6.3 Market Drivers and Opportunities
        • 6.3.1 Potential Applications
        • 6.3.2 Emerging Markets/Countries

      7 Global Active Transdermal Drug Delivery Device Manufacturers Profiles/Analysis

      • 7.1 Novartis AG
        • 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.1.2 Active Transdermal Drug Delivery Device Product Category, Application and Specification
          • 7.1.2.1 Product A
          • 7.1.2.2 Product B
        • 7.1.3 Novartis AG Active Transdermal Drug Delivery Device Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.1.4 Main Business/Business Overview
      • 7.2 Noven Pharmaceuticals, Inc.
        • 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.2.2 Active Transdermal Drug Delivery Device Product Category, Application and Specification
          • 7.2.2.1 Product A
          • 7.2.2.2 Product B
        • 7.2.3 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.2.4 Main Business/Business Overview
      • 7.3 Transdermal Corp.
        • 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.3.2 Active Transdermal Drug Delivery Device Product Category, Application and Specification
          • 7.3.2.1 Product A
          • 7.3.2.2 Product B
        • 7.3.3 Transdermal Corp. Active Transdermal Drug Delivery Device Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.3.4 Main Business/Business Overview
      • 7.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
        • 7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.4.2 Active Transdermal Drug Delivery Device Product Category, Application and Specification
          • 7.4.2.1 Product A
          • 7.4.2.2 Product B
        • 7.4.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.4.4 Main Business/Business Overview
      • 7.5 Mylan N.V.
        • 7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.5.2 Active Transdermal Drug Delivery Device Product Category, Application and Specification
          • 7.5.2.1 Product A
          • 7.5.2.2 Product B
        • 7.5.3 Mylan N.V. Active Transdermal Drug Delivery Device Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
        • 7.5.4 Main Business/Business Overview
      • 7.6 3M
        • 7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.6.2 Active Transdermal Drug Delivery Device Product Category, Application and Specification
          • 7.6.2.1 Product A
          • 7.6.2.2 Product B
        • 7.6.3 3M Active Transdermal Drug Delivery Device Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.6.4 Main Business/Business Overview
      • 7.7 Actavis, Inc.
        • 7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.7.2 Active Transdermal Drug Delivery Device Product Category, Application and Specification
          • 7.7.2.1 Product A
          • 7.7.2.2 Product B
        • 7.7.3 Actavis, Inc. Active Transdermal Drug Delivery Device Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.7.4 Main Business/Business Overview
      • 7.8 Bayer AG
        • 7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.8.2 Active Transdermal Drug Delivery Device Product Category, Application and Specification
          • 7.8.2.1 Product A
          • 7.8.2.2 Product B
        • 7.8.3 Bayer AG Active Transdermal Drug Delivery Device Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.8.4 Main Business/Business Overview
      • 7.9 Boehringer Ingelheim GmbH
        • 7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.9.2 Active Transdermal Drug Delivery Device Product Category, Application and Specification
          • 7.9.2.1 Product A
          • 7.9.2.2 Product B
        • 7.9.3 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.9.4 Main Business/Business Overview
      • 7.8 Corium International, Inc.
        • 7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.10.2 Active Transdermal Drug Delivery Device Product Category, Application and Specification
          • 7.10.2.1 Product A
          • 7.10.2.2 Product B
        • 7.10.3 Corium International, Inc. Active Transdermal Drug Delivery Device Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.10.4 Main Business/Business Overview
      • 7.11 Echo Therapeutics, Inc.
      • 7.12 GlaxoSmithKline plc

      8 Active Transdermal Drug Delivery Device Manufacturing Cost Analysis

      • 8.1 Active Transdermal Drug Delivery Device Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
        • 8.1.4 Market Concentration Rate of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
        • 8.2.1 Raw Materials
        • 8.2.2 Labor Cost
        • 8.2.3 Manufacturing Expenses
      • 8.3 Manufacturing Process Analysis of Active Transdermal Drug Delivery Device

      9 Industrial Chain, Sourcing Strategy and Downstream Buyers

      • 9.1 Active Transdermal Drug Delivery Device Industrial Chain Analysis
      • 9.2 Upstream Raw Materials Sourcing
      • 9.3 Raw Materials Sources of Active Transdermal Drug Delivery Device Major Manufacturers in 2017
      • 9.4 Downstream Buyers

      10 Marketing Strategy Analysis, Distributors/Traders

      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
        • 10.1.3 Marketing Channel Development Trend
      • 10.2 Market Positioning
        • 10.2.1 Pricing Strategy
        • 10.2.2 Brand Strategy
        • 10.2.3 Target Client
      • 10.3 Distributors/Traders List

      11 Market Effect Factors Analysis

      • 11.1 Technology Progress/Risk
        • 11.1.1 Substitutes Threat
        • 11.1.2 Technology Progress in Related Industry
      • 11.2 Consumer Needs/Customer Preference Change
      • 11.3 Economic/Political Environmental Change

      12 Global Active Transdermal Drug Delivery Device Market Forecast (2018-2025)

      • 12.1 Global Active Transdermal Drug Delivery Device Capacity, Production, Revenue Forecast (2018-2025)
        • 12.1.1 Global Active Transdermal Drug Delivery Device Capacity, Production and Growth Rate Forecast (2018-2025)
        • 12.1.2 Global Active Transdermal Drug Delivery Device Revenue and Growth Rate Forecast (2018-2025)
        • 12.1.3 Global Active Transdermal Drug Delivery Device Price and Trend Forecast (2018-2025)
      • 12.2 Global Active Transdermal Drug Delivery Device Production, Consumption , Import and Export Forecast by Region (2018-2025)
        • 12.2.1 North America Active Transdermal Drug Delivery Device Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.2 Europe Active Transdermal Drug Delivery Device Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.3 China Active Transdermal Drug Delivery Device Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.4 Japan Active Transdermal Drug Delivery Device Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.5 Southeast Asia Active Transdermal Drug Delivery Device Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.6 India Active Transdermal Drug Delivery Device Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
      • 12.3 Global Active Transdermal Drug Delivery Device Production, Revenue and Price Forecast by Type (2018-2025)
      • 12.4 Global Active Transdermal Drug Delivery Device Consumption Forecast by Application (2018-2025)

      13 Research Findings and Conclusion

        14 Appendix

        • 14.1 Methodology/Research Approach
          • 14.1.1 Research Programs/Design
          • 14.1.2 Market Size Estimation
          • 14.1.3 Market Breakdown and Data Triangulation
        • 14.2 Data Source
          • 14.2.1 Secondary Sources
          • 14.2.2 Primary Sources

        Summary:
        Get latest Market Research Reports on Active Transdermal Drug Delivery Device . Industry analysis & Market Report on Active Transdermal Drug Delivery Device is a syndicated market report, published as Global Active Transdermal Drug Delivery Device Market Research Report 2019. It is complete Research Study and Industry Analysis of Active Transdermal Drug Delivery Device market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $2,900.00
        $5,800.00
        2,328.70
        4,657.40
        2,723.10
        5,446.20
        448,166.00
        896,332.00
        242,382.00
        484,764.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report